viewAminex PLC

Aminex bolsters board


Aminex (LON:AEX) has strengthened its board by making senior managers directors of the company.

The East African gas group, which is focused on the Ruvuma basin in Tanzania (onshore), has added chief executive Jay Bhattacherjee and chief operating officer Philip Thompson to the board.

Their appointments followed the acquisition of privately-owned Canyon Oil & Gas, which they both founded, funded through the issue of 80mln Aminex shares.

Chief financial officer Max Williams, who has been with the company for a number of years, joins the board as finance director.

Brian Hall meanwhile has stepped down as acting chairman and will remain as chairman for “as long as required”, while exploration director Mike Rego is leaving the board and the company to pursue other opportunities.

The new and existing board members will now own around an eighth of the company’s shares.

“Jay Bhattacherjee and Philip Thompson have been working with the company as consultants for several months and we are pleased to cement the relationship through their appointments to the Board,” said Hall.

“They have each acquired substantial holdings in the company through vending their own company into Aminex for shares and following this up with material cash contributions in the recent successful placing.”

Quick facts: Aminex PLC

Price: 1.26 GBX

Market: LSE
Market Cap: £47.51 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Aminex PLC named herein, including the promotion by the Company of Aminex PLC in any Content on the Site, the Company receives from said issuer...


Market Report: FTSE gets an injection of optimism from US Remdesivir approval

FTSE 100 got a lift as a first treatment for COVID-19, remdesivir, was approved in the US. London’s leading index added 41 points to 5,826 in early dealings. Gilead Inc (NASDAQ:GILD) produces remdesivir and it is said to cut COVID-19 recovery times by five days. According to the World Health...

1 day, 19 hours ago

2 min read